Headline – half yearly point bonus edition
Summary of June 2026 on RonnyAllan.NET
June was similar to the other months of this year but slightly down on the previous two months due to holiday. Still a strong blog performance. Other key targets met were three more editions of the Spotlight series on primary NET types (colon, thymic and ovarian). See my Spotlight series. Also a recent focus on clinical trials (mostly updates) and a revision of alpha-emitter PRRT.
I had many shares on many posts in June – know this, every share helps someone understand or even work towards a diagnosis, discovery of the best doctors and treatments, questions to ask about this, that and the other. The top posts this month really shows the breadth of subjects applicable to Neuroendocrine Cancer that needs to be considered. Click on the each of the 10 posts to read.
I wish I could do more but there’s just little old me! And Chris too of course for those following my exploits on Facebook Page Ronny Allan. Fortunately I have a great 2IC and admin team in my private group, so that runs as normal but also takes up a huge amount of my time.
- I’ll list the top 10 performing blog posts in Jun 2026. I can assure you there is some great information in there, and you may have missed some of my latest blogs which made it to the top 10. Click the blue heading or the picture on each. Every share spreads awareness and you could potentially save someone’s life. Includes 4 bonus posts.
- I’ll provide a year to date summary for 2026.
- I’ll provide the top performing post from each of my Facebook pages in the month of June (very often this is different from the top posts by views). For those not aware of my 3 Facebook public pages, I normally post my new blog posts on my Facebook page Neuroendocrine Cancer and/or World Neuroendocrine Cancer Day. Holiday photos, personal stuff, and often some areas of amusement are normally published on my Facebook page Ronny Allan (although I sometimes sneak one in on these monthly reviews or on the main blog outlets).
I’m thankful to the loyal supporters on my blog site and the other social media sites day and night (and I do note some doing both!). I really am very grateful and probably would have given up long ago, were it not for your support.
The top 10 performing posts in Jun 2026
1. Foundation knowledge. Click here or on the graphic to read what is an already acclaimed useful post.
2. Small Tumours Big Impact. A new hard hitting awareness post published in June 2026. Based on a theme used by several specialists over the years and something I see in my patient group daily. They may be small but they have a huge impact on health. Worth a share – it’s great awareness. Click here or on the graphic below to read.
3. Chemotherapy for Neuroendocrine Neoplasms. Unexpected item in the bagging area! This one seemed to resonate more than it normally does, a surprise number 3. But it is an update. Click here to read or on the photo below.
4. This was very popular in June, more than when I first published it with my descriptive and catchy graphic. Click here or on the photo below. Can you see it? Someone said this was the best post about NET awareness ever.
5. I guess it picks up many views outside the community. Not complaining! Click here or on the photo below.
6. . Another new awareness post published in June 2026. Click here or on the photo below to read more.
7. An old favourite of mine – clearly you guys like it too. Click here or on the photo below.
8. It almost went viral when published. Thanks for supporting it – see further below to see how it fares in 2026 so far. Click here or on the photo below to read more.
9. ! New clinical trial published in June 2026. Click here or on the photo below to read more.
10. PRRT – The Sequel? Alpha-emitter PRRT for Neuroendocrine Tumours (NET) A major refresh – check it out. Click here or on the photo below to read more.
Bonus stuff in Jun 2026
Bonus 1. It’s important not to follow the herd. Click here or on the photo below to read more.
Bonus 2. Steve Jobs. Click here or on the photo below to read more.
Bonus 3. 10 questions. “a must read if just diagnosed”. Click here or on the photo below to read more.

Bonus 4. Random post on my smallest page but had a huge impact. Click here or on the photo below to read more.

2026 half year Performance
(click title in blue to read – see list below)
Facebook Performance June 2026 – Top performing post
Facebook Page Neuroendocrine Cancer (blog mainly). Some big numbers on this page in June but this one was top by a country mile. Click here to see the Facebook post or click on the graphic below to go direct to the blog post to which it refers
Facebook Page World Neuroendocrine Cancer Day (blog focussed on awareness). It was also mentioned above. Someone obviously shared that in a high volume area – many thanks to that person/those persons. Click here to see the Facebook post (and join in) or on the graphic below to go direct to the blog post to which it refers
Page Ronny Allan (personal NET stuff plus travel, humour, interesting stuff not in my blog). Click here or on the graphic below. Sometimes the simplest and quickest to create posts end up on top.
Special feature – My Patient Group
The group was an afterthought. In terms of the largest patient groups across the world, mine is the newest but has grown into the biggest, perhaps the international flavour helps. In terms of membership sources, US, UK, Canada, Australia, South Africa, New Zealand, Ireland, India, Germany and Netherlands dominate making almost 90% of the group membership. I estimate over 13,000 membership in the summer! Not as rare as you think!
Click here and answer all questions to join my private Facebook group

Thanks for reading and sharing the newsletter. If you think someone might benefit from reading this newsletter, feel free to share.
Thanks for reading.
Ronny
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me. Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Clinical Trials PRRT: From 177Lu to 225Ac: The LM3 Antagonist Journey Toward High‑LET PRRTJune 24, 2026Clinical Trials and Research
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient Advocacy
SYHX2008: A New Self‑Injectable subcutaneous Long‑acting Octreotide on the Horizon for NETsJune 22, 2026Clinical Trials and Research
PRRT – The Sequel? Alpha-emitter PRRT for Neuroendocrine Tumours (NET)October 26, 2024Clinical Trials and ResearchDiscover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.






















